Extrapulmonary small‐cell carcinoma compared with small‐cell lung carcinoma [PDF]
İrfan Çiçin +9 more
openalex +1 more source
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
G. Hudes +18 more
semanticscholar +1 more source
The cGAS‐STING pathway boosts HCC antitumor immunity but lacks specific activation. Nanoplatform ZMRPF induces HCC ferroptosis via lipid ROS, releasing mtDNA. It synergizes with ZMRPF‐released Mn2⁺ to activate cGAS‐STING, amplifies antigen‐presenting cell activity, reverses HCC immunosuppression, and enables robust systemic antitumor immunity ...
Yuchen Zhang +13 more
wiley +1 more source
Fine-needle aspiration cytology reduces the frequency of surgeries for malignant salivary gland tumors. [PDF]
Mayer M +16 more
europepmc +1 more source
CD24, a Novel Cancer Biomarker, Predicting Disease-Free Survival of Non-small Cell Lung Carcinomas: A Retrospective Study of Prognostic Factor Analysis from the Viewpoint of Forthcoming (Seventh) New TNM Classification [PDF]
Hyun Ju Lee +5 more
openalex +1 more source
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.
N. Weidner +3 more
semanticscholar +1 more source
Synthetic Nanobiology Actuated Lipometabolic Cell Factory for Autologous Tumor Immunotherapy
FA plays a crucial role in the interaction between tumor cells and the tumor microenvironment, especially for the immune response. A biocatalytic immunoenhancement strategy is developed to boost antitumor immunity by FA metabolic orientation to ceramide. Through the design of this delicate catalytic immunoenhancement strategy, the synthetic nanobiology
Shoujie Zhao +8 more
wiley +1 more source
Grading of bladder cancer: updates, controversies and practical solutions. [PDF]
Downes MR +3 more
europepmc +1 more source
p16 INK4a hypermethylation and p53, p16 and MDM2 protein expression in Esophageal Squamous Cell Carcinoma [PDF]
Noushin Taghavi +8 more
openalex +1 more source

